Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 21, 2014; 20(31): 10900-10907
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10900
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10900
Criteria-specific long-term survival prediction model for hepatocellular carcinoma patients after liver transplantation
Fei Teng, Gui-Hua Wang, Yi-Feng Tao, Wen-Yuan Guo, Zheng-Xin Wang, Guo-Shan Ding, Xiao-Min Shi, Zhi-Ren Fu, Organ Transplantation Institute of Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
Author contributions: Teng F and Wang GH contributed equally to this work; Teng F designed the study and wrote the paper, while Wang GH collected and analyzed the data; all authors contributed to the manuscript.
Supported by the Foundation of Shanghai Science and Technology Commission NO. 134119a7300 and Shanghai Changzheng Hospital Foundation for Young Scientists NO. 2012CZQN08 and NO. 2012CZQN01
Correspondence to: Zhi-Ren Fu, MD, Organ Transplantation Institute of Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai 200003, China. zhirenf@vip.sina.com
Telephone: +86-21-81885741 Fax: +86-21-63276788
Received: December 27, 2013
Revised: February 15, 2014
Accepted: May 12, 2014
Published online: August 21, 2014
Revised: February 15, 2014
Accepted: May 12, 2014
Published online: August 21, 2014
Core Tip
Core tip: This study was conducted to establish a model to predict long-term survival of hepatocellular carcinoma (HCC) patients after liver transplantation (MHCAT) with reference to different criteria and peri-transplant risk factors. We found that MHCAT can effectively predict long-term survival for HCC patients, but needs to be verified by multi-center retrospective or randomized controlled trials.